Tag: licensing
-
Science-Based Enterprises: Great Ideas Beat Venture Capital
14 February 2014. Three entrepreneurs starting companies based on science described how they got their businesses off the ground, with ground-breaking science in many cases more important than a large stash of venture capital. San Diego entrepreneurs John Newsam, Irwin Jacobs, and Han Cao told of their start-up business experiences today at a session of…
-
Start-Up Developing Gene Therapies Lands $45M in Early Funds
12 February 2014. Voyager Therapeutics, a new start-up in Cambridge, Massachusetts creating gene therapies for disorders of the central nervous system, gained $45 million in first-round financing. Third Rock Ventures, a venture capital company specializing in life science enterprises, provided the funds for the company founded by researchers at University of Massachusetts Medical School, University…
-
European Venture Licenses Biotech Drought-Resistant Traits
Genective, a joint venture between German and French seed companies to develop new corn varieties, is licensing engineered gene science from the biotechnology company Arcadia Biosciences Inc. in Davis, California. Arcadia Biosciences will receive initial, milestone, and sales royalty payments under the agreement, but the dollar amount of the deal was not disclosed. Arcadia Biosciences…
-
South Carolina Partnership Licenses First Technology
SCRA, a South Carolina state business investment organization in Columbia, and TAO Life Sciences, a medical device commercialization company in Greenville, say they completed their first licensing deal for a chest drainage tube device invented by students at Clemson University. Financial aspects of the licensing agreement were not disclosed. Bioengineering students at Clemson University designed…
-
Heart Vessel Surgical Glue Shown Effective in Animal Tests
Surgeons and biomedical engineers at Boston Children’s and Brigham and Women’s hospitals and Massachusetts Institute of Technology, developed a non-toxic, biocompatible surgical glue that in tests with pigs patches heart defects, such as those in large blood vessels. The team led by Boston Children’s Pedro del Nido and Jeffrey Karp of Brigham and Women’s Hospital…
-
MedImmune, Biotech to Partner on Cancer Immunotherapies
MedImmune in Gaithersburg, Maryland, the biologics division of pharmaceutical company AstraZeneca, and Immunocore Ltd. in Oxford, U.K. will develop cancer treatments that harness the body’s immune system, based on Immunocore’s technology. The deal will pay Immunocore, for each therapy program licensed by MedImmune, $20 million initially and another $300 million in milestone payments, as well…
-
NIH Giving In-Kind Technical Services for Rare Diseases
National Institutes of Health (NIH) is supporting three new projects with technical research services for two companies and one university lab developing therapies for rare diseases. The projects aim to develop treatments for acute radiation syndrome, brain injury following cardiac arrest, and beta thalassemia, a rare blood disorder. The awards are a product of the…
-
Start-Up Licenses UMass Cancer Immunotherapy Technology
Agalimmune Ltd., a new start-up enterprise in London, U.K. and Irvine, California, licensed research discoveries from University of Massachusetts Medical School in Worcester to develop treatments for solid tumors that harness the power of the patient’s immune system. Financial details of the agreement were not disclosed. The technology licensed from UMass, called Alphaject by the…
-
Neurotherapies Require Collaboration, Team Science, Big Data
In a briefing today on Capitol Hill, University of Pennsylvania biomedical engineer and neurologist Brian Litt outlined requirements for harnessing promising research for patients suffering from brain disorders. The briefing in Washington, D.C. was organized by the journal Science Translational Medicine and its publisher American Association for the Advancement of Science. Litt, who is on…
-
Challenge Seeks Endothelial Progenitor Cell Culture Process
A new challenge on InnoCentive is seeking a technique for storing and growing endothelial progenitor cells captured from blood samples and vital for research on and testing for various disorders. The competition has a purse of $25,000 and a deadline of 5 January 2014 for submissions. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowd-sourcing competitions for…